|
XRN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47859510693615E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33630000293184E-08 |
| Normal-vs-Stage2 |
2.06119999957011E-08 |
| Normal-vs-Stage3 |
6.36810049137182E-10 |
| Normal-vs-Stage4 |
3.94040000628593E-09 |
| Stage1-vs-Stage2 |
3.026400E-02 |
| Stage1-vs-Stage3 |
4.125900E-02 |
| Stage1-vs-Stage4 |
2.136000E-02 |
| Stage2-vs-Stage3 |
5.292000E-01 |
| Stage2-vs-Stage4 |
9.598800E-01 |
| Stage3-vs-Stage4 |
4.751800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91960003448344E-10 |
| Normal-vs-AfricanAmerican |
7.577300E-03 |
| Normal-vs-Asian |
1.35459999994758E-06 |
| Caucasian-vs-AfricanAmerican |
2.138600E-01 |
| Caucasian-vs-Asian |
8.331400E-01 |
| AfricanAmerican-vs-Asian |
2.074800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2006999949854E-08 |
| Normal-vs-Female |
6.08429973070201E-10 |
| Male-vs-Female |
3.888000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.03279999996708E-06 |
| Normal-vs-Age(41-60Yrs) |
1.59489976780947E-10 |
| Normal-vs-Age(61-80Yrs) |
2.81579981553648E-10 |
| Normal-vs-Age(81-100Yrs) |
4.222800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.240000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.192210E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.691600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.559000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.208200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.585800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.421600E-02 |
| Classical-VS-Follicular |
1.515020E-03 |
| Classical-VS-Other |
2.389600E-01 |
| Classical-VS-Normal |
2.62710000420441E-08 |
| Tall-VS-Follicular |
9.063200E-01 |
| Tall-VS-Other |
9.820200E-01 |
| Tall-VS-Normal |
5.71270000193635E-08 |
| Follicular-VS-Other |
9.351000E-01 |
| Follicular-VS-Normal |
1.26540000700004E-09 |
| Other-VS-Normal |
4.819100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.5970004752528E-11 |
| Normal-vs-N1 |
2.9452000005481E-07 |
| N0-vs-N1 |
9.875800E-01 |
|
|
